đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to compare the immune response, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-05
Trial ID
NCT00290303
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
To evaluate the persistence of antibodies against hepatitis B at 30, 42, 54...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-04-21
Trial ID
NCT00343915
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
In this study, subjects who received primary neonatal vaccination with hepa...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04
Trial ID
NCT00657657
Treatments Being Tested
The purpose of the present trial is to evaluate 6 vaccine formulations of r...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1993-11
Trial ID
NCT00697970
Treatments Being Tested
This study evaluates the immunogenicity and safety of Infanrix hexa⢠(DTPa-...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-16
Trial ID
NCT01353703
Treatments Being Tested
This study will evaluate the persistence of immunity to hepatitis B 10 to 1...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-07
Trial ID
NCT01138098
Treatments Being Tested
REP 2139-Ca is nucleic acid polymer. Nucleic acid polymers have been previo...
Status
Completed
Location
Infectious Clinical Hospital ( n.a. Toma Ciorba)
Start Date
2014-09
Trial ID
NCT02233075
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781